← Leaderboards
Ronald Gibson
University Of Washington
$29,133
Attributed
$29,133
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4K · FY2005–07$2K$1.5K$1K$500$0
'05
'06
'07
Funding mix
By agency
NIH$29,133 · 6
By mechanism
M01$29,133 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Bonnie W Ramsey$21,623,756
- David W Raible$21,473,931
- Edwin W Rubel$15,520,530
- Margaret Rosenfeld$6,120,159
- Lisa L Cunningham$2,377,881
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisClinical ResearchHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationPatient Oriented ResearchAntibioticsMembrane PotentialsPseudomonas AeruginosaRespiratory InfectionsMicroorganism Disease ChemotherapyTechnology /Technique DevelopmentClinical TrialsInhalation Drug AdministrationElectrical PotentialInborn Metabolism Disorder DiagnosisChronicChloride ChannelsAntibiotics, AminoglycosideCell Surface ReceptorsBronchodilator AgentsAminoglycosidesControlled Clinical TrialsComputer Retrieval Of Information On Scientific Projects Database
Grant awards (8)
TRIAL EVALUATING AZTREONAM LYSINATE FOR INHALATION IN CF PTS WITH AIR-CF1$381
M01 · FY2007 · RR · contact PI
AZTREONAM FOR INHALATION TRIAL IN CF PTS WITH LUNG DISEASE DUE TO P AERUGINOSA$1,427
M01 · FY2005 · RR
A multicenter trial of topical aminoglycosides to activate CF genes$13,445
M01 · FY2004 · RR
Safety and tolerability study of Aztreonam in patients's with CF$6,073
M01 · FY2004 · RR
Inhalation of INS37217 for CF patients$5,205
M01 · FY2004 · RR
Aztreonam for inhalation trial in CF pts with lung disease due to P aeruginosa$2,602
M01 · FY2004 · RR
TRANSEPITHELIAL ELECTRICAL POTENTIAL DIFFERENCES ACROS$0
M01 · FY2002 · RR
TRANSEPITHELIAL ELECTRICAL POTENTIAL DIFFERENCES ACROS$0
M01 · FY2001 · RR